SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-16-001250
Filing Date
2016-03-24
Accepted
2016-03-24 17:27:00
Documents
3
Period of Report
2016-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 36956
2 EXHIBIT 99.2 - LETTER AGREEMENT, DATED AS OF MARCH 22, 2016 ex99-2.htm EX-99.2 22898
3 logo.jpg GRAPHIC 10022
  Complete submission text file 0001341004-16-001250.txt   75219
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161528112
SIC: 2834 Pharmaceutical Preparations